Active ingredientValganciclovirCat. No. P-V009-001CAS 175865-60-8Family · Pharmaceutical analytical standards
Valganciclovir
An oral prodrug of ganciclovir, approved in 2001 to treat cytomegalovirus retinitis in people with AIDS and to prevent cytomegalovirus disease after organ transplantation. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It is ganciclovir linked to the amino acid valine: this lets the gut's peptide transporters absorb it, raising the share that reaches the blood from 6-8% to about 60%.
Go to the active ingredient →Active ingredientValganciclovirCat. No. P-V009-001CAS 175865-60-8
Active ingredientValganciclovir HydrochlorideCat. No. P-V009-002CAS 175865-59-5
Pharmacopoeial impurityValganciclovir EP Impurity CCat. No. P-V009-004CAS 1202645-50-8
Pharmacopoeial impurityValganciclovir EP Impurity D HCl saltCat. No. P-V009-005CAS 1429306-09-1
Pharmacopoeial impurityValganciclovir EP Impurity RCat. No. P-V009-006CAS 1654737-32-2
Isotopically labelledrac-Valganciclovir-d5 (Mixture of Diastereomers)Cat. No. P-V009-007
Isotopically labelledrac-Valganciclovir-d5 HCl (Mixture of Diastereomers)Cat. No. P-V009-008
Isotopically labelledrac-Valganciclovir-d8 (Mixture of Diastereomers)Cat. No. P-V009-009
Isotopically labelledValganciclovir-d5 (Mixture of Diastereomers)Cat. No. P-V009-010
Isotopically labelledValganciclovir-d5 DiHCl (Mixture of Diastereomers)Cat. No. P-V009-011
Isotopically labelledValganciclovir-d8 (Mixture of Diastereomers)Cat. No. P-V009-013CAS 1132088-63-1
NitrosamineN-Nitroso ValganciclovirCat. No. P-V009-014
ImpurityValganciclovir Impurity 1Cat. No. P-V009-015CAS 130914-77-1
ImpurityD-Valganciclovir Hydrochloride (Mixture of Diastereomers)Cat. No. P-V009-016CAS 1393911-57-3
ImpurityIsovalarylganciclovirCat. No. P-V009-017CAS 1219792-41-2
ImpurityN-(L-Valyl) Valganciclovir HydrochlorideCat. No. P-V009-018
ImpurityN-Carbobenzyloxy-L-valinyl-ganciclovirCat. No. P-V009-019CAS 194154-40-0
ImpurityO-Acetyl N-Benzyloxycarbonyl ValganciclovirCat. No. P-V009-020CAS 194159-22-3
ImpurityS, S-Isovalganciclovir Impurity HydrochlorideCat. No. P-V009-021CAS 1401562-13-7
ImpurityValganciclovir Dimer Stereoisomer A, B, C DihydrochlorideCat. No. P-V009-022CAS 1401661-96-8
ImpurityValganciclovir Impurity 2 (Mixture of Tautomeric Isomers)Cat. No. P-V009-023
ImpurityValganciclovir Impurity 3 (Mixture of Isomers)Cat. No. P-V009-024
ImpurityValganciclovir Impurity 4 (Mixture of Diastereomers)Cat. No. P-V009-025
ImpurityValganciclovir Impurity 5 (Mixture of Diastereomers)Cat. No. P-V009-026
ImpurityValganciclovir Impurity 6 (Mixture of Isomers)Cat. No. P-V009-027
ImpurityValganciclovir Related Compound G (2R)Cat. No. P-V009-028CAS 1356353-76-8
ImpurityValganciclovir Related Compound G (2S)Cat. No. P-V009-029CAS 1356932-88-1No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceValganciclovir hydrochloride CRSEDQM code Y0002359Family ValganciclovirNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.